Jie-yi Shi
Key Laboratory Of Carcinogenesis And Cancer Invasion Of Ministry Of Education
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Erratum: Mitogen-activated protein kinase kinase kinase 4 deficiency in intrahepatic cholangiocarcinoma leads to invasive growth and epithelial-mesenchymal transition.
Journal: Hepatology (Baltimore, Md.)
Published: April 07, 2025
Erratum: Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition.
Journal: Hepatology (Baltimore, Md.)
Published: February 18, 2025
Erratum: CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: February 17, 2025
Mining the interpretable prognostic features from pathological image of intrahepatic cholangiocarcinoma using multi-modal deep learning.
Journal: BMC medicine
Published: October 11, 2023
The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome.
Journal: Clinical and translational medicine
Published: February 22, 2020
Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate Poor Outcome in Hepatocellular Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 19, 2018
CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: December 21, 2017
Last Updated: 09/26/2026